Publications by authors named "E E Sengupta"

Article Synopsis
  • Medical AI has the potential to enhance healthcare by improving evidence-based practice, personalizing treatment, cutting costs, and enhancing experiences for providers and patients.
  • MedPerf is introduced as an open platform designed for benchmarking medical AI models, enabling federated evaluation across healthcare organizations while maintaining data privacy.
  • The text outlines the challenges in healthcare AI, highlights the design and current status of MedPerf, and calls for collaboration from researchers and organizations to advance the platform.
View Article and Find Full Text PDF

Study Design: Non-interventional, cross-sectional pilot study.

Objectives: To establish the validity and reliability of the BioStamp nPoint biosensor (Medidata Solutions, New York, NY, USA [formerly MC10, Inc.]) for measuring electromyography in individuals with cervical spinal cord injury (SCI) by comparing the surface electromyography (sEMG) metrics with the Trigno wireless electromyography system (Delsys, Natick, MA, USA).

View Article and Find Full Text PDF

Sustainable Development Goals (SDG) are at the forefront of government initiatives across the world. The SDGs are primarily concerned with promoting sustainable growth via ensuring wellbeing, economic growth, environmental legislation, and academic advancement. One of the most prominent goals of the SDG is to provide learners with high-quality education (SDG 4).

View Article and Find Full Text PDF

The world is diving deeper into the digital age, and the sources of first information are moving towards social media and online news portals. The chances of being misinformed increase multifold as our reliance on sources of information are getting ambiguous. Traditional news sources followed strict codes of practice to verify stories, whereas today, users can upload news items on social media and unverified portals without proving their veracity.

View Article and Find Full Text PDF

Background: Increasingly, drug and device clinical trials are tracking activity levels and other quality of life indices as endpoints for therapeutic efficacy. Trials have traditionally required intermittent subject visits to the clinic that are artificial, activity-intensive, and infrequent, making trend and event detection between visits difficult. Thus, there is an unmet need for wearable sensors that produce clinical quality and medical grade physiological data from subjects in the home.

View Article and Find Full Text PDF